AGP Executive Report
Last update: 9 hours agoEbola Drug Trial Prep: Mauritius-headquartered Xylomed Pharmaceuticals says it has developed a candidate Ebola treatment and is planning a double-blind, randomised Phase 3B clinical trial in DRC, Uganda and South Sudan, aiming to test whether the medicine stops the virus from replicating. Marine Health & Pollution Monitoring: Scientists from 21 African countries, including Mauritius, are meeting in Accra to harmonise microplastics monitoring protocols for coastal waters using nuclear and isotopic techniques, to support comparable data and stronger environmental policies. Autism Support in Winter: South Africa’s Star Academy is expanding autism early-intervention programmes through the mid-year winter term, using individualised plans based on Applied Behaviour Analysis to help families maintain progress. Food Security Shock: A WTO note warns that conflict in the Persian Gulf has disrupted urea and phosphate fertiliser trade via the Strait of Hormuz, raising risks of shortages, higher prices and knock-on effects for farm yields and food security. Local Wellness Travel: Emirates is rolling out next-generation premium lounges, with Mauritius scheduled for August and “wellness-focused amenities” for travellers.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
